🟨 Climax Run - $TLRY exampleI have covered this in my education blog, but here is a great example of a Climax Run Stock
Checklist
✅ Price looks almost vertical
❌ Run occurs after at least 18 weeks of the first base. (This run is 5 weeks after first base)
✅ Rapid advancement +180%
✅ Last 8 days before drop was 7 out of 8 days up
✅ Last 2 trading days we saw the largest trading range
❌ Stock is not extended above 200d MA - since no 200 days of trading (early IPO)
❌ No Stock splits
Trade ideas
Tlry earningsTlry will report earnings next week. Support and resistance are shown and can potentially hit $3.32 which is apart of the resistance line and 50 EMA. If it can break above that, we can see this hit around the $4.50 range. If the earnings are bad this can go back down to its support around $2.48-2.34.
TLRY earnings on MondayTLRY Q2 November 2022 earnings are on Monday 1/9/2023 at 7am. Tilray Brands (TLRY) reported a Q1 August 2022 loss of $0.08 per share on revenue of $153.2 million. The consensus estimate was a loss of $0.06 per share on revenue of $155.7 million. Revenue fell 8.8% compared to the same quarter a year ago. The company said it continues to expect Adjusted EBITDA of $70 million to $80 million for the year ending December 31, 2022. I'm posting this as a long because of the higher probability, lower risk, current technical setup entry point. TLRY at $2.75 is near its major support level on the TTCATR(beta) indicator, plus there's a bullish cross setup on piRSI indicator now also. Here's TLRY levels on the 1-day chart:
Q2 November 2022 consensus:
EPS = -$0.05
Revenue = $158.29M
SMA200 = $4.07
SMA20 Triangular Trend Channel ATR(beta):
top = $4.92
R3 = $4.62
R2 = $4.32
R1 = $4.03
pivot = $3.73
S1 = $3.43
S2 = $3.13
S3 = $2.83
bottom = $2.53
Do your own due diligence, your risk is 100% your responsibility. This is for educational and entertainment purposes only. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Good luck and happy trading friends...
*3x lucky 7s of trading*
7pt Trading compass:
Price action, entry/exit
Volume average/direction
Trend, patterns, momentum
Newsworthy current events
Revenue
Earnings
Balance sheet
7 Common mistakes:
+5% portfolio trades, capital risk management
Beware of analyst's motives
Emotions & Opinions
FOMO : bad timing, the market is ruthless, be shrewd
Lack of planning & discipline
Forgetting restraint
Obdurate repetitive errors, no adaptation
7 Important tools:
Trading View app!, Brokerage UI
Accurate indicators & settings
Wide screen monitor/s
Trading log (pencil & graph paper)
Big, organized desk
Reading books, playing chess
Sorted watch-list
Checkout my indicators:
Fibonacci VIP - volume
Fibonacci MA7 - price
pi RSI - trend momentum
BBMC - bollinger bands
TTC - trend channel
AlertiT - notification
tickerTracker - MFI Oscillator
www.tradingview.com
TLRY Tilray Brands One of My TOP Stock Picks for 2023TLRY Tilray Brands is close to the pandemic low on a huge Falling Wedge and a Double Bottom Chart Pattern.
Looking at the TLRY Tilray Brands options chain, I would buy the $3 strike price Calls with
2023-1-20 expiration date for about
$0.16 premium.
TLRY Tilray Brands is One of My TOP Stock Picks for 2023!
Looking forward to read your opinion about it.
Weed companies are going to zero?TILRAY. Weekly chart.
Fake CHoC and feak breakout. Hope you have an opportunity to SELL it.
After 2.64 you have fib levels on 1.48 and who knows whats next.
We also have large weekly support ar 2.43, so be careful there.
We can touch it and then rebounce until 5.12 which is obviuosly Bullish CHoC.
SUMM:
SHORT — NOW
STOP 5.12
LONG — ONLY IF IT BREAKS 5.12
TLRY LongThe Play
TLRY has had a 30%+ pullback from the recent highs stemming from the December 2, 2022, recent legislation that was signed by President Biden. The strategy is to take advantage of a likely 10-15% rally in the short term.
Legislation: Highlights
After unanimous consent from the Senate, President Biden signed into law the Medical Marijuana and Cannabidiol Research Expansion Act, an act aimed at providing federal support to facilitate research of cannabis and its potential health benefits.
Legislation: Who’s Impacted
The medical community, including researchers in the bio-medical field, and those interested in the pharmaceutical applications of cannabis, as well as patients in need of more treatment options. The research will also help inform lawmakers, cannabis businesses, and consumers.
Things to look out for
The S&P500, or the general market, is in an overall bearish trend and showing signs of resistance after a recent 2-month bull rally.
About the company
Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia, and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK.
$TLRY Ready for Measured Move Takeoff Marijuana stocks look to have finally bottomed for a real short term rally, that can maybe turn into something else. I would think people are booking profits from being short all year and that tax loss selling in these names are done.
In any case, the whole space looks ready for a real short cover rally. I have here some channel analysis that is providing some measured move targets.
Tilray for the fishermanSpecial request chart
But I’m along dcaing weed stonks
It looks to be breaking out
This next couple of months is key
Mid term target is 17.50 but if it breaks up from there and if we’re right about stonks still being bull overall and if dollar has topped- weed bubble 2.0 is a possibility
GRI 2022
TLRY - Looks Set To Break Out With Indexes 🚀🌒TLRY appears to be consolidating my previous first target 1:0.618 @ $3.42 just as NDX looks set to break out and so I think this is the anchoring fib that will prove to either be the bottom or a significant low.
Also earnings is coming up shortly and would you believe the 1:1 fib time extension for this 3 wave pattern is almost exactly at earnings.
Its as if its been scripted 😄.
So I think TLRY is about to rocket 🚀.
Bought LEAP puts due to high IV which can pay for my calls, alternatively can buy the stock.
Not advice.
Tilray moving averagesYesterday cannabis stocks moved higher on news. Here's TLRY moving averages on the 1-day chart:
SMA50 = 3.51
SMA100 = 3.63
SMA150 = 4.35
SMA200 = 4.89
52wk high = 13.95
52wk low = 2.65
Do your own due diligence, your risk is 100% your responsibility. This is for educational and entertainment purposes only. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Good luck and happy trading friends...
*3x lucky 7s of trading*
7pt Trading compass:
Price action, entry/exit
Volume average/direction
Trend, patterns, momentum
Newsworthy current events
Revenue
Earnings
Balance sheet
7 Common mistakes:
+5% portfolio trades, capital risk management
Beware of analyst's motives
Emotions & Opinions
FOMO : bad timing, the market is ruthless, be shrewd
Lack of planning & discipline
Forgetting restraint
Obdurate repetitive errors, no adaptation
7 Important tools:
Trading View app!, Brokerage UI
Accurate indicators & settings
Wide screen monitor/s
Trading log (pencil & graph paper)
Big, organized desk
Reading books, playing chess
Sorted watch-list
Checkout my indicators:
Fibonacci VIP - volume
Fibonacci MA7 - price
pi RSI - trend momentum
TTC - trend channel
AlertiT - notification
tickerTracker - MFI Oscillator
www.tradingview.com
TLRY Short | LT entry target $2.08NASDAQ:TLRY
Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. It offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. The company operates Tilray Medical, a medical platform that provides GMP-certified flowers, oils, vapes, edibles, and topicals. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Tilray , Inc. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York.
TLRY Earnings are expected to be released on the 6th of October.
A break below $3.08 could potential lead to an ATL of $2.08
Tilray: Extended W or Head&ShouldersIt's not certain yet but I see high probability for an Extended W pattern (double bottom) or a Head&Shoulders pattern (triple bottom).
First target=4.50
After the first target, there are two probabilities:
A) It may break the resistance and keep on rising.
B) Or, it may turn back from 4.50, form a "head and shoulders/triple bottom pattern" and then rocket!
Mid & long term targets might be very high, since the share is too far away from its ATH.






















